Showing results (1-10 of 39) with videos related to
Sort By:
Pageof 4
Postgraduate Medicine|April 1, 1996
Risk stratification after acute myocardial infarction: which studies are best?V M FigueredoPostgraduate Medicine|February 1, 1997
The effects of alcohol on the heart: detrimental or beneficial?V M FigueredoInternational Journal of Clinical Practice|August 20, 2011
Statins in non-ischaemic cardiomyopathy: an update on our current clinical and pathophysiological understandingN Verma, V M FigueredoConference Proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference|February 3, 2007
Mobile telemedicine system for home care and patient monitoringM V M Figueredo, J DiasCurrent Opinion in Cardiology|May 1, 1995
Basic mechanisms of myocardial dysfunction: cellular pathophysiology of heart failureV M Figueredo, S A CamachoCurrent Opinion in Cardiology|May 1, 1994
Basic mechanisms of myocardial dysfunction: cellular pathophysiology of heart failureV M Figueredo, S A CamachoThe Journal of Antimicrobial Chemotherapy|July 1, 1988
Synergy of ciprofloxacin with fosfomycin in vitro against Pseudomonas isolates from patients with cystic fibrosisV M Figueredo, H C NeuEuropean Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|July 13, 2002
Lipomatus hypertrophy of the atrial septum and prominent crista terminalis appearing as a right atrial massJ R Pharr, V M FigueredoPostgraduate Medicine|December 1, 1994
Adjuvants to thrombolysis after acute myocardial infarction. Does adding antiplatelet agents, antithrombotics, or angioplasty make a difference?V M Figueredo, T M Amidon, C L WolfePostgraduate Medicine|December 1, 1994
Thrombolysis after acute myocardial infarction. Who should be added to inclusion criteria?V M Figueredo, T M Amidon, C L WolfePageof 4